Cefprozil Market

Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.

Cefprozil Market contains market size and forecasts of Cefprozil in global, including the following market information:

• Global Cefprozil Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Cefprozil Market Sales, 2017-2022, 2023-2028, (T)
• Global top five Cefprozil companies in 2021 (%)

The global Cefprozil market was valued at 138.9 million in 2021 and is projected to reach US$ 172.7 million by 2028, at a CAGR of 3.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anhydrous Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cefprozil include Orchid, Taj Pharma, Dhanuka, Lupin, Alkem, Corden Pharma, Aurobindo, Covalent and TEVA GROUP, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cefprozil manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cefprozil Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (T)

Global Cefprozil Market Segment Percentages, by Type, 2021 (%)

• Anhydrous
• Monohydrate

Global Cefprozil Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (T)

Global Cefprozil Market Segment Percentages, by Application, 2021 (%)

• Pharyngitis or tonsillitis
• Otitis Media
• Acute Sinusitis
• Secondary Bacterial Infection
• Uncomplicated Skin
• Other

Global Cefprozil Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (T)

Global Cefprozil Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cefprozil revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Cefprozil revenues share in global market, 2021 (%)
• Key companies Cefprozil sales in global market, 2017-2022 (Estimated), (T)
• Key companies Cefprozil sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Orchid
• Taj Pharma
• Dhanuka
• Lupin
• Alkem
• Corden Pharma
• Aurobindo
• Covalent
• TEVA GROUP
• Hetero Drugs
• Qilu Antibiotics
• Dongying Pharma
• Union Chempharma
• Huafangpharm
• Topfond